Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of ARTICLE PREMIER is 1.5% (moderate). The 2024 annual accounts show equity of €26k and a net result of €3k. Equity remains stable across the filed fiscal years (±0.5% per year). The company has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 7 annual accounts.
Signals
1 signal · with evidenceSignals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Trust signals
3 signalsAdministrative Flags
0 eventsBankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €6k |
| Net profit | €3k |
| Cash flow | €5k |
| Staff costs | - |
| Income taxes | €975 |
| Dividends | €4k |
| Total assets | €32k |
| Equity | €26k |
| Debt | €6k |
| of which ≤ 1y | €6k |
| of which > 1y | - |
| Working capital | €7k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 2.27 |
| Quick ratio | 2.27 |
| Working capital ratio | 23.2% |
| Solvency | 81.8% |
| Debt / equity | 0.22 |
| Long-term debt ratio | - |
| Interest coverage | 38.89 |
| Gross margin | - |
| Net margin | - |
| ROA | 9.0% |
| ROE | 11.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €32k |
| Fixed assets | 21/28 | €19k |
| Tangible fixed assets | 22/27 | €19k |
| Financial fixed assets | 28 | €30 |
| Current assets | 29/58 | €13k |
| Amounts receivable within one year | 40/41 | €6k |
| Cash & bank | 54/58 | €7k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €32k |
| Equity | 10/15 | €26k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €2k |
| Accumulated profits (losses) | 14 | €6k |
| Amounts payable | 17/49 | €6k |
| Amounts payable within one year | 42/48 | €6k |
| Trade debts payable within one year | 44 | €860 |
| Income statement | ||
| Gross operating margin | 9900 | €8k |
| Operating result | 9901 | €4k |
| Financial charges | 65 | €161 |
| Result before taxes | 9903 | €4k |
| Income taxes | 67/77 | €975 |
| Net result for the period | 9904 | €3k |
| Result to be appropriated | 9905 | €3k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Directors
Directors & mandates
1 director-
Current15-06-2021 → present
2 events
- 15-06-2021 Resigned· Manager
- 15-06-2021 Mandate renewed· Director
Insolvency mandates
indexingLegal Structure
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 10-08-1993 |
| Status | Active |
| Postal code | 1050 |
Structure & network
Connections & network
3 connected companiesLocations & real estate
Registered office
on the map · from the address registerEstablishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21447B0309/00C020 ProtectedMonumentVoormalig Chirurgisch Instituut van Dokter Depage en voormalig Nationaal Instituut van het BloedSource ↗ |
Brussels | 4,192 m² | 1 · 1,055 m² | 21.2 m · 6 fl. |
| 21013B0335/00A008 | Brussels | 121 m² | 1 · 119 m² | 28.9 m · 9 fl. |
Analysis
Snowflake analysis
financial profile on 5 axesExceptional profile, strong across almost every axis.
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameFR | ARTICLE PREMIER |